EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Assessing Insights Regarding Clinical Utility and Optimal Applicability of Glipizide + Metformin Fixed-Dose Combination in Elderly Type 2 Diabetes Mellitus Indian Patients (ASHA-Elderly India)

Ambika G Unnikrishnan, Manish Shetty, Samkit Shah, Manoj Chitale, Dishank Patel, Gopinath Reddy, Mahesh Marda, Senthil Sampath, Kannan A. Samy, Animesh Maiti, Partha S. Mandal, Amarta Chowdhury und 8 weitere

Chronicle of Diabetes Research and Practice · 2026-07 · 5 (2) · 60-70

DOI: 10.4103/cdrp.cdrp_2_26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chronicle of Diabetes Research and Practice, online erschienen am 17.07.2026. Verfasst von Ambika G Unnikrishnan und 19 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Managing elderly patients with type 2 diabetes mellitus (T2DM) is complex due to comorbidities, hypoglycemia risk, polypharmacy, renal issues, and costs. This survey evaluated Indian healthcare professionals’ (HCPs) perceptions regarding the clinical usefulness of the glipizide + metformin fixed-dose combination (FDC) for elderly patients with T2DM.

Methods

This cross-sectional, questionnaire-based survey was conducted to evaluate the knowledge, attitudes, and practices (KAP) of Indian HCPs supplemented by expert insights from focus group discussions (FGDs) concerning the clinical utility of this FDC for elderly patients with T2DM. Data were collected using a structured, self-administered questionnaire developed from a comprehensive literature review on the efficacy, safety, clinical utility, and prescribing patterns of the FDC.

Results

Of the 833 HCPs, 585 (70.22%) identified hypoglycemia as the main challenge in managing elderly T2DM patients. Cost and accessibility of medications were concerns for 449 (53.90%) HCPs, while 446 (53.54%) noted that renal impairment affected the drug metabolism. Key priorities for oral hypoglycemic agents included reducing the risk of hypoglycemia by 579 (69.51%) HCPs, perceived cost-related considerations by 527 (63.27%), and minimizing renal clearance by 447 (53.66%). A total of 571 (68.55%) HCPs preferred glipizide for its short half-life and renal safety. Approximately 419 (50.30%) HCPs supported this FDC use in mild-to-moderate renal impairment with dose adjustment.

Conclusion

Healthcare professionals in India perceived this FDC as a cost-effective choice for elderly T2DM patients, citing lower hypoglycemia risk, renal safety, and reduced pill burden. Highlight its clinical value and benefit for personalised T2DM management in the elderly.

Zitieren

APA

Unnikrishnan, A. G., Shetty, M., Shah, S., Chitale, M., Patel, D., Reddy, G., Marda, M., Sampath, S., Samy, K. A., Maiti, A., Mandal, P. S., Chowdhury, A., Singh, S., Sharma, A., Singh, J., Nema, A., Jhingan, A., Gupta, A., Kesarkar, R. N., & Pednekar, A. (2026). Assessing Insights Regarding Clinical Utility and Optimal Applicability of Glipizide + Metformin Fixed-Dose Combination in Elderly Type 2 Diabetes Mellitus Indian Patients (ASHA-Elderly India). Chronicle of Diabetes Research and Practice, 5(2), 60-70. https://doi.org/10.4103/cdrp.cdrp_2_26

Vancouver

Unnikrishnan AG, Shetty M, Shah S, Chitale M, Patel D, Reddy G, et al. Assessing Insights Regarding Clinical Utility and Optimal Applicability of Glipizide + Metformin Fixed-Dose Combination in Elderly Type 2 Diabetes Mellitus Indian Patients (ASHA-Elderly India). Chronicle of Diabetes Research and Practice. 2026;5(2):60-70. doi:10.4103/cdrp.cdrp_2_26

BibTeX
@article{Unnikrishnan2026,
  author = {Unnikrishnan, Ambika G and Shetty, Manish and Shah, Samkit and Chitale, Manoj and Patel, Dishank and Reddy, Gopinath and Marda, Mahesh and Sampath, Senthil and Samy, Kannan A. and Maiti, Animesh and Mandal, Partha S. and Chowdhury, Amarta and Singh, Shailendra and Sharma, Amit and Singh, Jaspreet and Nema, Ashish and Jhingan, Ashok and Gupta, Aneesha and Kesarkar, Rohan N. and Pednekar, Abhijit},
  title = {Assessing Insights Regarding Clinical Utility and Optimal Applicability of Glipizide + Metformin Fixed-Dose Combination in Elderly Type 2 Diabetes Mellitus Indian Patients (ASHA-Elderly India)},
  journal = {Chronicle of Diabetes Research and Practice},
  year = {2026},
  volume = {5},
  number = {2},
  pages = {60--70},
  doi = {10.4103/cdrp.cdrp_2_26}
}
Kostenlos starten →